Vodafone Business Services (VBS), the enterprise arm of Vodafone India, has collaborated with Diabetacare to launch dCare Smart, a device that helps people manage diabetes better.
An industry first, dCare Smart, is a GSM SIM enabled wireless glucometer that empowers people to proactively monitor their blood sugar levels which is powered by Vodafone's Machine to Machine (M2M) embedded cellular technology.
The device transmits blood sugar results to a secure Diabetacare server, where they are constantly monitored by Diabetes Specialist Clinicians at the Diabetacare's Diabetes Management Centre (DMC).
In case of any abnormal blood glucose readings, both the patient and kin receive an alert/call with expert advice from the DMC immediately.
Further, the dCare Smart is powered by Vodafone's Machine to Machine (M2M) embedded cellular technology. It is paired with the back-end clinical servers which connect directly to the electronic medical record system, wherein access is given to patients and their caregivers to keep them informed and better manage the condition.
Nick Gliddon, Director - Vodafone Business Services says, "Vodafone is renowned globally for being a leader in M2M solutions and is driving the Internet of Things (IoT) by connecting machines, devices and objects to the internet, turning them into ‘intelligent' assets that communicate with the world around them globally for more than 20 years. Leveraging our global expertise, we are the first telecom service provider to offer the M2M service platform in the Indian market today."
He added, "Vodafone's M2M Solution for Diabetacare allows data to be securely uploaded to a central server and is then accessed remotely by multiple parties. This Diabetacare deployment is a reflection of our strong, successful and differentiated approach to M2M in India. There is a huge opportunity in this country and we have the capability to maintain over 10 billion SIMs in our platform. We are confident of growing this business further, especially in segments like healthcare."
Sharing his views on the initiative and launch of dCare Smart, Dr. Sanjiv Agarwal, Founder & Managing Director, Diabetacare said, "We looked at alternatives but, for me, Vodafone's M2M solution is ahead of the game. Beyond the technology, Vodafone was able to demonstrate a real problem-solving attitude. Vodafone's global M2M solutions will help Diabetacare fulfil its plans to ramp up deployments to 100,000 users across multiple locations."
He further added, "Diabetacare is a mainstream proposition and the service is priced to make it affordable. Vodafone's scale and global coverage means the business needs just one supplier, fully managed from a single platform. It means Diabetacare is ready to respond quickly to growth opportunities worldwide."